FathomX

fathomx.co

FathomX is a Digital Health AI spin-off from the National University of Singapore, focusing on enhancing mammogram screening through its flagship product, Fx Mammo. This AI Assistant reduces false positive/negative rates and streamlines clinical workflows, requiring fewer radiologists per screen. With over three years of research backing its algorithm, FathomX has established a strong presence in the Asia Pacific healthcare market, securing collaborations with major hospitals and a co-development deal with Hewlett Packard Enterprise. The company has also gained recognition through various competitions and media features, positioning itself as a leader in AI-driven healthcare solutions.